[1]
Sedeh, F.B. et al. 2022. Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis. Acta Dermato-Venereologica. 102, (Aug. 2022), adv00764. DOI:https://doi.org/10.2340/actadv.v102.2075.